Literature DB >> 19753574

Retrievable vena cava filters: a clinical review.

Marianne Tschoe1, Hyun S Kim, Daniel J Brotman, Michael B Streiff.   

Abstract

Vena cava filters were developed as a method of preventing pulmonary embolism (PE) in patients with venous thromboembolism (VTE) at risk for bleeding from therapeutic anticoagulation. However, the long-term complications of filter placement, such as caval thrombosis, have mitigated some of the benefits, particularly in those patients with only a temporary contraindication to anticoagulation. Retrievable filters were designed to avoid the long-term risks of a permanent filter while still providing short-term protection against PE. As a result, their use has expanded from patients with known thrombosis to those without VTE who are at high risk for developing PE. In this review, we discuss the different types of retrievable filters, indications for their placement, complications that can occur during and after placement, and their use as prophylaxis in surgical patients. Although the use of retrievable filters in patients with known VTE is clear, further studies are needed to establish their prophylactic efficacy in the surgical patient. Until this evidence is available, we recommend that retrievable filters should be used only in patients with acute VTE who are at risk for recurrent thromboembolism and have a transient risk for bleeding. Copyright 2009 Society of Hospital Medicine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19753574     DOI: 10.1002/jhm.439

Source DB:  PubMed          Journal:  J Hosp Med        ISSN: 1553-5592            Impact factor:   2.960


  7 in total

1.  In vivo performance of gold nanoparticle-loaded absorbable inferior vena cava filters in a swine model.

Authors:  Steven Y Huang; Jossana A Damasco; Li Tian; Linfeng Lu; Joy Vanessa D Perez; Katherine A Dixon; Malea L Williams; Megan C Jacobsen; Stephen J Dria; Mitchell D Eggers; Adam D Melancon; Rick R Layman; Elizabeth M Whitley; Marites P Melancon
Journal:  Biomater Sci       Date:  2020-06-19       Impact factor: 6.843

2.  High inferior vena cava thrombosis in a 16-year-old postpartum patient: a case report.

Authors:  Yong Wei; Ping Ouyang; Wanhua Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-01-27

Review 3.  Inferior vena cava filters: current best practices.

Authors:  Anita Rajasekhar
Journal:  J Thromb Thrombolysis       Date:  2015-04       Impact factor: 2.300

4.  Retrievable inferior vena cava filters in patients with cancer are safe but are they beneficial?

Authors:  Sameh Mikhail; Lindsay Hannan; Michael J Pishvaian; Craig Kessler
Journal:  Med Oncol       Date:  2015-04-29       Impact factor: 3.064

5.  In vivo imaging of radiopaque resorbable inferior vena cava filter infused with gold nanoparticles.

Authors:  Li Tian; Patrick Lee; Burapol Singhana; Aaron Chen; Yang Qiao; Linfeng Lu; Jonathan Martinez; Ennio Tasciotti; Megan C Jacobsen; Adam Melancon; Mark McArthur; Mitch Eggers; Steve Huang; Marites P Melancon
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2018-03-13

6.  Cost-benefit analysis of establishing an inferior vena cava filter clinic.

Authors:  Joshua D Dowell; Summit H Shah; Kyle J Cooper; Vedat Yıldız; Xueliang Pan
Journal:  Diagn Interv Radiol       Date:  2017 Jan-Feb       Impact factor: 2.630

7.  Radiopaque Resorbable Inferior Vena Cava Filter Infused with Gold Nanoparticles.

Authors:  Li Tian; Patrick Lee; Burapol Singhana; Aaron Chen; Yang Qiao; Linfeng Lu; Jonathan O Martinez; Ennio Tasciotti; Adam Melancon; Steven Huang; Mitch Eggers; Marites P Melancon
Journal:  Sci Rep       Date:  2017-05-19       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.